menu
    • menu

    Company profile for Biocartis

    NEW Drugs in Dev: 1
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology which represents the fastest growing segment of the MDx market worldwide. Today, Biocartis of...
    Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology which represents the fastest growing segment of the MDx market worldwide. Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer, as well as tests for SARS-CoV-2 and sepsis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BiocartisBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Generaal de Wittelaan 11B B-2800 Mechelen
    Telephone
    Telephone
    +32 15 632 600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biocartis.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biocartis/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Paris Packaging Week

    Paris Packaging Week

    Not Confirmed

    envelop Contact Supplier

    Paris Packaging Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biocartis Partners With Mayo on Breast Cancer Gene Signatures
    Biocartis Partners With Mayo on Breast Cancer Gene Signatures

    13 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-13/biocartis-to-collaborate-with-mayo-clinic-on-breast-cancer-gene-signatures

    PHARMIWEB
    13 Jan 2026
    Share Share
    Biocartis NV: Partners With Mayo Clinic On Breast Cancer Gene
    Biocartis NV: Partners With Mayo Clinic On Breast Cancer Gene

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3217084/0/en/Press-Release-Biocartis-NV-Biocartis-to-collaborate-with-Mayo-Clinic-on-breast-cancer-gene-signatures.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Biocartis Highlights Idylla Platform Impact At AMP Conference
    Biocartis Highlights Idylla Platform Impact At AMP Conference

    17 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-17/biocartis-showcases-growing-impact-of-idylla-platform-at-amp-2025

    PHARMIWEB
    17 Nov 2025
    Share Share
    Biocartis Highlights Idylla Platform Impact At AMP 2025
    Biocartis Highlights Idylla Platform Impact At AMP 2025

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188411/0/en/Press-Release-Biocartis-NV-Biocartis-Showcases-Growing-Impact-of-Idylla-Platform-at-AMP-2025.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Biocartis NV Gets FDA Approval for Idylla™ CDx MSI Test
    Biocartis NV Gets FDA Approval for Idylla™ CDx MSI Test

    15 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/15/3150046/0/en/Press-Release-Biocartis-NV-Biocartis-Receives-FDA-Approval-for-the-Idylla-CDx-MSI-Test.html

    GLOBENEWSWIRE
    15 Sep 2025
    Share Share
    Mike Joins Biocartis as Sr. VP of Global Business Development
    Mike Joins Biocartis as Sr. VP of Global Business Development

    19 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-19/biocartis-welcomes-mike-kreitzinger-as-senior-vice-president-of-global-business-development

    PHARMAWEB
    19 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search